122 related articles for article (PubMed ID: 37005293)
1. Prognostic Factors for Distal Bile Duct Carcinoma After Surgery.
Kawahara R; Midorikawa R; Taniwaki S; Kojima S; Kanno H; Yoshitomi M; Nomura Y; Goto Y; Satou T; Sakai H; Ishikawa H; Hisaka T; Yasunaga M; Sakaue T; Ushijima T; Yasumoto M; Okabe Y; Tanigawa M; Naitou Y; Yano H; Okuda K
Kurume Med J; 2023 Jul; 68(2):81-89. PubMed ID: 37005293
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in patients with middle and distal bile duct cancers.
Kwon HJ; Kim SG; Chun JM; Lee WK; Hwang YJ
World J Gastroenterol; 2014 Jun; 20(21):6658-65. PubMed ID: 24914391
[TBL] [Abstract][Full Text] [Related]
3. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma].
Liang JW; Zhao P; Zhou ZX; Tian YT; Zhao DB; Wang CF
Zhonghua Wai Ke Za Zhi; 2009 May; 47(9):677-80. PubMed ID: 19615237
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for radical resection of middle and distal bile duct cancer.
Nomura T; Tsuchiya Y; Nashimoto A; Yabusaki H; Takii Y; Nakagawa S; Sato N; Kanbayashi C; Tanaka O
Hepatogastroenterology; 2009; 56(90):294-8. PubMed ID: 19579585
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma of the middle bile duct: is bile duct segmental resection appropriate?
Lee HG; Lee SH; Yoo DD; Paik KY; Heo JS; Choi SH; Choi DW
World J Gastroenterol; 2009 Dec; 15(47):5966-71. PubMed ID: 20014461
[TBL] [Abstract][Full Text] [Related]
6. The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma.
Kawai M; Tani M; Kobayashi Y; Tsuji T; Tabuse K; Horiuchi T; Oka M; Yamaguchi K; Sakata Y; Shimomura T; Yamaue H
Am J Surg; 2010 Apr; 199(4):447-52. PubMed ID: 19596119
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer.
Yoshida T; Matsumoto T; Sasaki A; Morii Y; Aramaki M; Kitano S
Arch Surg; 2002 Jan; 137(1):69-73. PubMed ID: 11772220
[TBL] [Abstract][Full Text] [Related]
8. Disease recurrence patterns and analysis of clinicopathological prognostic factors for recurrence after resection for distal bile duct cancer.
Choi SB; Han HJ; Park PJ; Kim WB; Song TJ; Kim JS; Suh SO; Choi SY
Am Surg; 2015 Mar; 81(3):289-96. PubMed ID: 25760206
[TBL] [Abstract][Full Text] [Related]
9. Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study.
Petrova E; Rückert F; Zach S; Shen Y; Weitz J; Grützmann R; Wittel UA; Makowiec F; Hopt UT; Bronsert P; Kühn F; Rau BM; Izrailov RE; Khatkov IE; Lapshyn H; Bolm L; Bausch D; Keck T; Wellner UF; Seifert G
Langenbecks Arch Surg; 2017 Aug; 402(5):831-840. PubMed ID: 28612115
[TBL] [Abstract][Full Text] [Related]
10. Para-aortic lymph node metastasis in carcinoma of the distal bile duct.
Yoshida T; Aramaki M; Bandoh T; Kawano K; Sasaki A; Matsumoto T; Morii Y; Kitano S
Hepatogastroenterology; 1998; 45(24):2388-91. PubMed ID: 9951929
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment and postoperative outcomes for middle and lower bile duct carcinoma in Japan--experience of a single institute.
Suzuki M; Unno M; Oikawa M; Endo K; Katayose Y; Matsuno S
Hepatogastroenterology; 2000; 47(33):650-7. PubMed ID: 10919005
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of the number of metastatic lymph nodes in distal bile duct cancer: An analysis of Japanese registration cases by the study group for biliary surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Ishihara S; Horiguchi A; Endo I; Wakaki T; Hirano S; Yamaue H; Yamamoto M
J Hepatobiliary Pancreat Sci; 2020 Jul; 27(7):396-401. PubMed ID: 32128955
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up.
Bahra M; Jacob D; Langrehr JM; Neumann UP; Neuhaus P
J Hepatobiliary Pancreat Surg; 2008; 15(5):501-7. PubMed ID: 18836804
[TBL] [Abstract][Full Text] [Related]
15. Comparison of pancreaticoduodenectomy and bile duct resection for middle bile duct cancer: A multi-center collaborating study of Japan and Korea.
Hayashi H; Jang JY; Kim KS; Choi JS; Takahara T; Choi SH; Hirano S; Yu HC; Uemura S; Unno M
J Hepatobiliary Pancreat Sci; 2020 Jun; 27(6):289-298. PubMed ID: 32048467
[TBL] [Abstract][Full Text] [Related]
16. Benefits and limitations of middle bile duct segmental resection for extrahepatic cholangiocarcinoma.
Akita M; Ajiki T; Ueno K; Tsugawa D; Tanaka M; Kido M; Toyama H; Fukumoto T
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):147-152. PubMed ID: 32037277
[TBL] [Abstract][Full Text] [Related]
17. P16 hypermethylation predicts surgical outcome following curative resection of mid/distal bile duct cancer.
Park JS; Park YN; Lee KY; Kim JK; Yoon DS
Ann Surg Oncol; 2013 Aug; 20(8):2511-7. PubMed ID: 23478949
[TBL] [Abstract][Full Text] [Related]
18. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection.
Choi SB; Park SW; Kim KS; Choi JS; Lee WJ
J Surg Oncol; 2009 May; 99(6):335-42. PubMed ID: 19226533
[TBL] [Abstract][Full Text] [Related]
19. Is Pancreaticoduodenectomy Feasible for Recurrent Remnant Bile Duct Cancer Following Bile Duct Segmental Resection?
Lee JG; Lee SH; Lim JH; Park JS; Yoon DS; Kim KS
J Gastrointest Surg; 2015 Dec; 19(12):2138-45. PubMed ID: 26341821
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma of the gallbladder: an appraisal of surgical resection.
Chijiiwa K; Tanaka M
Surgery; 1994 Jun; 115(6):751-6. PubMed ID: 7910985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
